Among the different type III IFNs, IFN-λ3 appears to be associated with the extent of lupus activity and, in particular, with active serosal and cutaneous disease, which may be triggered by anti-Ro/SSA antibodies [114]. Here, CALR is linked to systemic lupus erythematosus.